Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20120910010800N4Phase 3Completed
Phase 3 trial of ropivacaine in cough, Post-extubation sore throat (POST) and dysphonia, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Post-extubation cough, Post-extubation sore throat and 1 more. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20120910010800N4.